Xarelto Claims to be Heard in Coming Year Through Bellwether Trials

Written By:
Jessie Paluch
Jessie Paluch

Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.

This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.

TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.

Xarelto Claims to be Heard in Coming Year Through Bellwether Trials

According to the Louisiana Record, over 9,000 Xarelto claims have been brought across the U.S. against the makers and distributors of the anticoagulant drug Xarelto, the majority centralized in multidistrict litigation (MDL) in the Eastern District of Louisiana under U.S. District Court Judge Eldon Fallon.

Another 1,000 cases have been filed in state court in Philadelphia, Pennsylvania, and an additional 1,000 are pending in Delaware.

xarelto claims heard bellwether trials
Table of Contents

Judge Chooses Four Xarelto Claims to Push Through the Bellwether Trial Process

Judge Fallon has picked four Xarelto claims to serve as bellwether lawsuits from the MDL to be tried during 2017.

These include:

  • The first case, scheduled for February 2017, involves a Louisiana man who alleges that he suffered severe gastrointestinal bleeding after using Xarelto.
  • The second lawsuit to be tried in Louisiana has been brought by the husband of a woman who died from a brain hemorrhage approximately one month after she began taking Xarelto.
  • The third trial, which will be held in Mississippi, relates to a woman who claims to have suffered intestinal bleeding after using Xarelto to treat blood clots.
  • The fourth case involves a Texas man who died due to gastrointestinal bleeding resulting from the use of Xarelto.

Although the results of these bellwether cases are not binding on the other Xarelto lawsuits in the MDL, they will likely set the tone for the Xarelto Case as a whole and settlement discussions, and be used to help determine whether a settlement can be reached.

If no settlement is possible or the defendants are determined to be entirely at fault, the cases may be sent back to their home districts.

The defendants in the Xarelto cases are German drug maker Bayer AG and its U.S. distributor, Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson.

Xarelto Claims Result From Over 10,000 Reported Adverse Event

According to a report released in July 2016 by the Institute for Safe Medication Practices (ISMP), there was a total of 10,674 adverse event reports associated with Xarelto in 2015, including 1,121 patient deaths and 4,508 injuries that required hospitalization.

The most common reports were of bleeding on the brain and in the intestines.

Xarelto Claims to be Heard in Coming Year Through Bellwether Cases will be updated as the Xarelto lawsuits move forward.

Written By:
Jessie Paluch
Jessie Paluch

Experienced Attorney & Legal SaaS CEO

With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three.  She spent the first decade of her career working as an international tax attorney at Deloitte.

In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.

In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!

Camp Lejeune Lawsuit

Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.

Tylenol Lawsuit

Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.

AFFF Lawsuit

Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.

Do You
Have A Case?

Here, at TruLaw, we’re committed to helping victims get the justice they deserve.

Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

Helpful Sites & Resources